AI assistant
IONIS PHARMACEUTICALS INC — Director's Dealing 2011
Jan 3, 2011
30591_dirs_2011-01-03_e504289a-1ad6-4edb-8067-b9c2b3ffa88c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ISIS PHARMACEUTICALS INC (ISIS)
CIK: 0000874015
Period of Report: 2011-01-03
Reporting Person: CROOKE STANLEY T (Director, Chairman, President, CEO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-01-03 | Employee Stock Option (right to buy) | $10.29 | A | 122096 | Acquired | 2018-01-02 | Common Stock (122096) | Direct |
| 2011-01-03 | Employee Stock Option (right to buy) | $10.29 | A | 15000 | Acquired | 2018-01-02 | Common Stock (15000) | Indirect |
Footnotes
F1: Grant of 1-3-11 to reporting person of stock options under the Isis Pharmaceuticals, Inc. 1989 Stock Option Plan. 25% of the shares subject to the option will vest and become exercisable on 1-3-12. Thereafter, the remaining shares subject to the option vest and become exercisable in 36 equal monthly installments, at the rate of 30,524 shares per year. The option is exercisable as to 0 shares on 1-3-11.
F2: Grant of 1-3-11 to reporting person's wife of stock options under the Isis Pharmaceuticals, Inc. 1989 Stock Option Plan. 25% of the shares subject to the option will vest and become exercisable on 1-3-12. Thereafter, the remaining shares subject to the option vest and become exercisable in 36 equal monthly installments, at the rate of 3,750 shares per year. The option is exercisable as to 0 shares on 1-3-11.